258 related articles for article (PubMed ID: 28774731)
21. Structure-activity relationship analysis of curcumin analogues on anti-influenza virus activity.
Ou JL; Mizushina Y; Wang SY; Chuang DY; Nadar M; Hsu WL
FEBS J; 2013 Nov; 280(22):5829-40. PubMed ID: 24034558
[TBL] [Abstract][Full Text] [Related]
22. Discovery of dapivirine, a nonnucleoside HIV-1 reverse transcriptase inhibitor, as a broad-spectrum antiviral against both influenza A and B viruses.
Hu Y; Zhang J; Musharrafieh RG; Ma C; Hau R; Wang J
Antiviral Res; 2017 Sep; 145():103-113. PubMed ID: 28778830
[TBL] [Abstract][Full Text] [Related]
23. Design of inhibitors of influenza virus membrane fusion: synthesis, structure-activity relationship and in vitro antiviral activity of a novel indole series.
Brancato V; Peduto A; Wharton S; Martin S; More V; Di Mola A; Massa A; Perfetto B; Donnarumma G; Schiraldi C; Tufano MA; de Rosa M; Filosa R; Hay A
Antiviral Res; 2013 Aug; 99(2):125-35. PubMed ID: 23707194
[TBL] [Abstract][Full Text] [Related]
24. Multivalent peptide dendrimers inhibit the fusion of viral-cellular membranes and the cellular NF-κB signaling pathway.
Xie X; He J
Eur J Med Chem; 2022 Feb; 230():114140. PubMed ID: 35085860
[TBL] [Abstract][Full Text] [Related]
25. Antiviral activity and possible mechanisms of action of pentagalloylglucose (PGG) against influenza A virus.
Liu G; Xiong S; Xiang YF; Guo CW; Ge F; Yang CR; Zhang YJ; Wang YF; Kitazato K
Arch Virol; 2011 Aug; 156(8):1359-69. PubMed ID: 21479599
[TBL] [Abstract][Full Text] [Related]
26. CL-385319 inhibits H5N1 avian influenza A virus infection by blocking viral entry.
Liu S; Li R; Zhang R; Chan CC; Xi B; Zhu Z; Yang J; Poon VK; Zhou J; Chen M; Münch J; Kirchhoff F; Pleschka S; Haarmann T; Dietrich U; Pan C; Du L; Jiang S; Zheng B
Eur J Pharmacol; 2011 Jun; 660(2-3):460-7. PubMed ID: 21536025
[TBL] [Abstract][Full Text] [Related]
27. Optimization of 4-Aminopiperidines as Inhibitors of Influenza A Viral Entry That Are Synergistic with Oseltamivir.
Gaisina IN; Peet NP; Cheng H; Li P; Du R; Cui Q; Furlong K; Manicassamy B; Caffrey M; Thatcher GRJ; Rong L
J Med Chem; 2020 Mar; 63(6):3120-3130. PubMed ID: 32069052
[TBL] [Abstract][Full Text] [Related]
28. A natural component from Euphorbia humifusa Willd displays novel, broad-spectrum anti-influenza activity by blocking nuclear export of viral ribonucleoprotein.
Chang SY; Park JH; Kim YH; Kang JS; Min JY
Biochem Biophys Res Commun; 2016 Mar; 471(2):282-9. PubMed ID: 26850850
[TBL] [Abstract][Full Text] [Related]
29. Design, synthesis and biological evaluation of novel L-ascorbic acid-conjugated pentacyclic triterpene derivatives as potential influenza virus entry inhibitors.
Wang H; Xu R; Shi Y; Si L; Jiao P; Fan Z; Han X; Wu X; Zhou X; Yu F; Zhang Y; Zhang L; Zhang L; Zhou D; Xiao S
Eur J Med Chem; 2016 Mar; 110():376-88. PubMed ID: 26866456
[TBL] [Abstract][Full Text] [Related]
30. Quercetin as an Antiviral Agent Inhibits Influenza A Virus (IAV) Entry.
Wu W; Li R; Li X; He J; Jiang S; Liu S; Yang J
Viruses; 2015 Dec; 8(1):. PubMed ID: 26712783
[TBL] [Abstract][Full Text] [Related]
31. Temporin G, an amphibian antimicrobial peptide against influenza and parainfluenza respiratory viruses: Insights into biological activity and mechanism of action.
De Angelis M; Casciaro B; Genovese A; Brancaccio D; Marcocci ME; Novellino E; Carotenuto A; Palamara AT; Mangoni ML; Nencioni L
FASEB J; 2021 Feb; 35(2):e21358. PubMed ID: 33538061
[TBL] [Abstract][Full Text] [Related]
32. Anti-Influenza A Viral Butenolide from
Li F; Chen D; Lu S; Yang G; Zhang X; Chen Z; Fan S; Wu S; He J
Viruses; 2018 Jul; 10(7):. PubMed ID: 29976861
[TBL] [Abstract][Full Text] [Related]
33. In Vitro and In Vivo Antiviral Activity of Nylidrin by Targeting the Hemagglutinin 2-Mediated Membrane Fusion of Influenza A Virus.
Jang Y; Shin JS; Lee JY; Shin H; Kim SJ; Kim M
Viruses; 2020 May; 12(5):. PubMed ID: 32466302
[TBL] [Abstract][Full Text] [Related]
34. Design, synthesis and biological evaluation of amino acids-oleanolic acid conjugates as influenza virus inhibitors.
Meng L; Su Y; Yang F; Xiao S; Yin Z; Liu J; Zhong J; Zhou D; Yu F
Bioorg Med Chem; 2019 Dec; 27(23):115147. PubMed ID: 31635892
[TBL] [Abstract][Full Text] [Related]
35. Synthesis, Structure Activity Relationship and Anti-influenza A Virus Evaluation of Oleanolic Acid-Linear Amino Derivatives.
Li W; Yang F; Meng L; Sun J; Su Y; Shao L; Zhou D; Yu F
Chem Pharm Bull (Tokyo); 2019 Nov; 67(11):1201-1207. PubMed ID: 31434835
[TBL] [Abstract][Full Text] [Related]
36. Synthesis, structure activity relationship and in vitro anti-influenza virus activity of novel polyphenol-pentacyclic triterpene conjugates.
Li H; Li M; Xu R; Wang S; Zhang Y; Zhang L; Zhou D; Xiao S
Eur J Med Chem; 2019 Feb; 163():560-568. PubMed ID: 30554131
[TBL] [Abstract][Full Text] [Related]
37. Porous gold nanoparticles for attenuating infectivity of influenza A virus.
Kim J; Yeom M; Lee T; Kim HO; Na W; Kang A; Lim JW; Park G; Park C; Song D; Haam S
J Nanobiotechnology; 2020 Mar; 18(1):54. PubMed ID: 32209114
[TBL] [Abstract][Full Text] [Related]
38. From Naproxen Repurposing to Naproxen Analogues and Their Antiviral Activity against Influenza A Virus.
Dilly S; Fotso Fotso A; Lejal N; Zedda G; Chebbo M; Rahman F; Companys S; Bertrand HC; Vidic J; Noiray M; Alessi MC; Tarus B; Quideau S; Riteau B; Slama-Schwok A
J Med Chem; 2018 Aug; 61(16):7202-7217. PubMed ID: 30028133
[TBL] [Abstract][Full Text] [Related]
39. Sialic acid-mimic peptides as hemagglutinin inhibitors for anti-influenza therapy.
Matsubara T; Onishi A; Saito T; Shimada A; Inoue H; Taki T; Nagata K; Okahata Y; Sato T
J Med Chem; 2010 Jun; 53(11):4441-9. PubMed ID: 20476787
[TBL] [Abstract][Full Text] [Related]
40. Identification of pyrrolo[3,2-c]pyridin-4-amine compounds as a new class of entry inhibitors against influenza viruses in vitro.
Chang SY; Cruz DJ; Ko Y; Min JY
Biochem Biophys Res Commun; 2016 Sep; 478(4):1594-601. PubMed ID: 27586275
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
